2023 | Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062 | Satake, Hironaga; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Yamaguchi, Kensei; Chen, Jen-Shi; Yoshikawa, Takaki; Amagai, Kenji; KUN-HUEI YEH ; Goto, Masahiro; Chao, Yee; Lam, Ka-On; Han, Shi Rong; Shiratori, Shinichi; Shah, Sukrut; Shitara, Kohei | Japanese journal of clinical oncology | 1 | 0 | |
2023 | Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer | Su, Yung-Yeh; Chiang, Nai-Jung; Yang, Yi-Hsin; Yen, Chia-Jui; Bai, Li-Yuan; Chiu, Chang-Fang; Chuang, Shih-Chang; SHIH HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chan, De-Chuan; Peng, Cheng-Ming; Chiu, Sz-Chi; Li, Chung-Pin; Shan, Yan-Shen; Chen, Li-Tzong | Cancers | 2 | 0 | |